[Inhalation and peroral mucolytic therapy in mucoviscidosis in children]. / Ingaliatsionnaia i peroral'naia mukoliticheskaia terapiia pri mukovistsidoze u detei.
Vopr Kurortol Fizioter Lech Fiz Kult
; (5): 15-8, 1996.
Article
em Ru
| MEDLINE
| ID: mdl-9036657
ABSTRACT
The paper summarizes the results of clinical studies of 98 children with mucoviscidosis whose age was 7 to 18 years. There is research evidence for possibility and expediency of using new classes of mucolytic agents in the therapy of mucoviscidosis in children. Analysis of the rheological properties of sputum showed the advantage of inhalation route of mucolytics over their oral administration. There is evidence for the advantage of mucosolvan over carbocysteine and unithiol via all routes of administration, the optimal methods of administration and differentiated indications have been developed.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Unitiol
/
Carbocisteína
/
Fibrose Cística
/
Expectorantes
/
Ambroxol
Limite:
Adolescent
/
Child
/
Child, preschool
/
Humans
/
Infant
Idioma:
Ru
Revista:
Vopr Kurortol Fizioter Lech Fiz Kult
Ano de publicação:
1996
Tipo de documento:
Article